Integrated Plasma and Tumor Proteomics of Nasopharyngeal Carcinoma in a Moroccan Cohort
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125771 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ayman Reffai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Canary Center for Cancer Early Detection, School of Medicine, Stanford University, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: Proteomics, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nasopharyngeal carcinoma (NPC) is a multifactorial disease mainly affecting the Southeast Asian and North African populations. Critically, there is a dearth of available circulating biomarkers for NPC. Additionally, as of this writing, there have been no prior plasma proteomics studies on NPC in the Moroccan population. Accordingly, there has been no integrated analysis of tumor and plasma for NPC in the Moroccan sub-population. Label-free proteomics analysis was conducted on 25 samples of Moroccan origin (10 NPC samples and 15 healthy control samples). Each sample was depleted of albumin, fractionated into eight fractions, and then analyzed using Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS). A total of 291 proteins and 2702 unique peptides were identified across all samples. In total, 16 proteins were differentially expressed (DEPs) between NPC cases and healthy individuals. Of these, three showed prognostic significance, while four demonstrated diagnostic potential. A pathway analysis showed significantly enriched terms related to the immune response and chronic inflammation, revealing acute-phase proteins as differentially expressed. The investigation of patients with early and advanced stages of NPC revealed two DEPs, while four additional DEPs were identified across the three defined clusters of NPC. Across all comparisons, DEPs, such as H2A, IGHG2, SERPINA3, SAA1, CRP, PIGR, and APOA2, have shown potential as biomarkers for NPC, with several being identified for the first time. We additionally compared the plasma proteomic profile of NPC with the tumor proteomic profile, highlighting that deeper proteomics analysis of plasma may be required to quantify additional putative biomarkers that may be shed from the tumor into the blood. Our research presents the first plasma proteomic profile of NPC in Morocco and North Africa, identifying proteins that might ultimately have diagnostic and prognostic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Canary Center for Cancer Early Detection, School of Medicine, Stanford University, Stanford, CA 94305, USA.
- Intelligent Automation and BioMed Genomics Laboratory, Biology Department, Faculty of Sciences and Techniques of Tangier, Abdelmalek Essaadi University-Tetouan, Tangier 90000, Morocco.
- Oncology Clinic of Tangier, Tangier 90000, Morocco.
- Mohamed VI Center for Cancer Treatment, Ibn Rochd University Hospital (CHU), Casablanca 20100, Morocco.
ORCID-Profile: Ayman Reffai, Abel Bermudez
Zitieren
APA
Reffai, A., Hori, M., Adusumilli, R., Bermudez, A., Haddad, H., Tawfiq, N., Pitteri, S., Bennani Mechita, M., & Mallick, P. (2025). Integrated Plasma and Tumor Proteomics of Nasopharyngeal Carcinoma in a Moroccan Cohort. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125771
Vancouver
Reffai A, Hori M, Adusumilli R, Bermudez A, Haddad H, Tawfiq N, et al. Integrated Plasma and Tumor Proteomics of Nasopharyngeal Carcinoma in a Moroccan Cohort. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125771
BibTeX
@article{Reffai2025,
author = {Reffai, Ayman and Hori, Michelle and Adusumilli, Ravali and Bermudez, Abel and Haddad, Houssam and Tawfiq, Nezha and Pitteri, Sharon and Bennani Mechita, Mohcine and Mallick, Parag},
title = {Integrated Plasma and Tumor Proteomics of Nasopharyngeal Carcinoma in a Moroccan Cohort},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125771}
}
EUVIMED